{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:38:37Z","timestamp":1778852317221,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Medical University of Gdansk","award":["ST-553"],"award-info":[{"award-number":["ST-553"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12890-017-0535-y","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T13:13:23Z","timestamp":1512998003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial"],"prefix":"10.1186","volume":"17","author":[{"given":"Piotr","family":"Janowiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Krajnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zygmunt","family":"Podolec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Bandurski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Damps-Konsta\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Soba\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Currow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Jassem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"key":"535_CR1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S2213-2600(17)30293-X","volume":"5","author":"JB Soriano","year":"2017","unstructured":"Soriano JB, Abajobir AA, Abate KH, Abera SF, Agrawal A, Ahmed MB, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990\u20132015: a systematic analysis for the global burden of disease study 2015. Lancet Respir Med. 2017;5:691\u2013706. 10.1016\/S2213-2600(17)30293-X .","journal-title":"Lancet Respir Med"},{"key":"535_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1191\/0269216305pm1056oa","volume":"19","author":"H Elkington","year":"2005","unstructured":"Elkington H, White P, Addington-Hall J, Higgs R, Edmonds P. The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat Med. 2005;19:485\u201391. https:\/\/doi.org\/10.1191\/0269216305pm1056oa .","journal-title":"Palliat Med"},{"key":"535_CR3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1155\/2011\/745047","volume":"18","author":"DD Marciniuk","year":"2011","unstructured":"Marciniuk DD, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P, et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian thoracic society clinical practice guideline. Can Respir J. 2011;18:69\u201378. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21499589","journal-title":"Can Respir J"},{"key":"535_CR4","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0024-3205(00)00434-3","volume":"66","author":"SE Zebraski","year":"2000","unstructured":"Zebraski SE, Kochenash SM, Raffa RB. Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea. Life Sci. 2000;66:2221\u201331. 10.1016\/S0024-3205(00)00434-3 .","journal-title":"Life Sci"},{"key":"535_CR5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/jjco\/29.12.600","volume":"29","author":"K Tanaka","year":"1999","unstructured":"Tanaka K, Shima Y, Kakinuma R, Kubota K, Ohe Y, Hojo F, et al. Effect of nebulized morphine in cancer patients with dyspnea: a pilot study. Jpn J Clin Oncol. 1999;29:600\u20133. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10721941","journal-title":"Jpn J Clin Oncol"},{"key":"535_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/026921639500900212","volume":"8","author":"M Farncombe","year":"1994","unstructured":"Farncombe M, Chater S, Gillin A. The use of nebulized opioids for breathlessness: a chart review. Palliat Med. 1994;8:306\u201312. 10.1177\/026921639500900212 .","journal-title":"Palliat Med"},{"key":"535_CR7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/026921639701100402","volume":"11","author":"G Zeppetella","year":"1997","unstructured":"Zeppetella G. Nebulized morphine in the palliation of dyspnoea. Palliat Med. 1997;11:267\u201375. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9373577","journal-title":"Palliat Med"},{"key":"535_CR8","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1136\/thorax.57.11.939","volume":"57","author":"A-L Jennings","year":"2002","unstructured":"Jennings A-L, Davies AN, Higgins JPT, Gibbs JSR, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57:939\u201344. 10.1136\/thorax.57.11.939 .","journal-title":"Thorax"},{"key":"535_CR9","first-page":"900","volume":"52","author":"RH Kallet","year":"2007","unstructured":"Kallet RH. The role of inhaled opioids and furosemide for the treatment of dyspnea. Respir Care. 2007;52:900\u201310. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17594733","journal-title":"Respir Care"},{"key":"535_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1513\/AnnalsATS.201501-034OC","volume":"12","author":"M Ekstr\u00f6m","year":"2015","unstructured":"Ekstr\u00f6m M, Nilsson F, Abernethy AA, Currow DC. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc. 2015;12:1079\u201392. 10.1513\/AnnalsATS.201501-034OC .","journal-title":"Ann Am Thorac Soc"},{"key":"535_CR11","doi-asserted-by":"publisher","first-page":"610921","DOI":"10.1155\/2012\/610921","volume":"2012","author":"M Shohrati","year":"2012","unstructured":"Shohrati M, Ghanei M, Harandi AA, Foroghi S, Harandi AA. Effect of nebulized morphine on dyspnea of mustard gas-exposed patients: a double-blind randomized clinical trial study. Pulm Med. 2012;2012:610921. 10.1155\/2012\/610921 .","journal-title":"Pulm Med"},{"key":"535_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/SPC.0000000000000072","volume":"8","author":"M Krajnik","year":"2014","unstructured":"Krajnik M, Jassem E, Sobanski P. Opioid receptor bronchial tree: current science. Curr Opin Support Palliat Care. 2014;8:191\u20139. 10.1097\/SPC.0000000000000072 .","journal-title":"Curr Opin Support Palliat Care"},{"key":"535_CR13","first-page":"145","volume":"5","author":"M Krajnik","year":"2006","unstructured":"Krajnik M, Podolec Z. Comparison of different methods of morphine inhalation in dyspnoea and cough. Pol Med Paliatywna. 2006;5:145\u201353.","journal-title":"Pol Med Paliatywna"},{"key":"535_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J Vestbo","year":"2013","unstructured":"Vestbo J, Hurd SS, Agust\u00ed AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347\u201365. 10.1164\/rccm.201204-0596PP .","journal-title":"Am J Respir Crit Care Med"},{"key":"535_CR15","volume-title":"Global strategy for the diagnosis, Managment, and prevention of chronic Obstuctive pulmonary disease (2017 report)","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)","year":"2017","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, Managment, and prevention of chronic Obstuctive pulmonary disease (2017 report). 2017. www.goldcopd.org ."},{"key":"535_CR16","volume-title":"Global strategy for the diagnosis, Managment, and prevention of chronic Obstuctive pulmonary disease (2011 report)","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)","year":"2011","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, Managment, and prevention of chronic Obstuctive pulmonary disease (2011 report). 2011. www.goldcopd.org ."},{"key":"535_CR17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.54.7.581","volume":"54","author":"JC Bestall","year":"1999","unstructured":"Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581\u20136. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10377201","journal-title":"Thorax"},{"key":"535_CR18","unstructured":"Urbaniak GC, Plous S. Research Randomizer (version 3.0). http:\/\/www.randomizer.org ."},{"key":"535_CR19","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1136\/thx.54.12.1099","volume":"54","author":"A Wilcock","year":"1999","unstructured":"Wilcock A, Crosby V, Clarke D, Corcoran R, Tattersfield A. Reading numbers aloud: a measure of the limiting effect of breathlessness in patients with cancer. Thorax. 1999;54:1099\u2013103. 10.1136\/thx.54.12.1099 .","journal-title":"Thorax"},{"key":"535_CR20","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1164\/rccm.201309-1634ST","volume":"188","author":"MA Spruit","year":"2013","unstructured":"Spruit MA, Singh SJ, Garvey C, Zu Wallack R, Nici L, Rochester C, et al. An official American thoracic society\/European respiratory society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:e13\u201364. 10.1164\/rccm.201309-1634ST .","journal-title":"Am J Respir Crit Care Med"},{"key":"535_CR21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1553-2712.2000.tb02231.x","volume":"7","author":"DJ Karras","year":"2000","unstructured":"Karras DJ, Sammon ME, Terregino CA, Lopez BL, Griswold SK, Arnold GK. Clinically meaningful changes in quantitative measures of asthma severity. Acad Emerg Med. 2000;7:327\u201334. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10805619","journal-title":"Acad Emerg Med"},{"key":"535_CR22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1081\/COPD-200050655","volume":"2","author":"AL Ries","year":"2005","unstructured":"Ries AL. Minimally clinically important difference for the UCSD shortness of breath questionnaire, Borg scale, and visual analog scale. COPD. 2005;2:105\u201310. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17136970","journal-title":"COPD"},{"key":"535_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S1579-2129(07)60112-8","volume":"43","author":"C Lisboa","year":"2007","unstructured":"Lisboa C, Leiva A, Pinochet R, Repetto P, Borzone G, D\u00edaz O. Reference values for Inspiratory capacity in healthy nonsmokers over age 50 years. Arch Bronconeumol. 2007;43:485\u20139. 10.1016\/S1579-2129(07)60112-8 .","journal-title":"Arch Bronconeumol"},{"key":"535_CR24","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R Pellegrino","year":"2005","unstructured":"Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948\u201368. 10.1183\/09031936.05.00035205 .","journal-title":"Eur Respir J"},{"key":"535_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","volume":"180","author":"HK Reddel","year":"2009","unstructured":"Reddel HK, Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW, et al. An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180:59\u201399. 10.1164\/rccm.200801-060ST .","journal-title":"Am J Respir Crit Care Med"},{"key":"535_CR26","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jpainsymman.2013.01.011","volume":"46","author":"MJ Johnson","year":"2013","unstructured":"Johnson MJ, Bland JM, Oxberry SG, Abernethy AP, Currow DC. Clinically important differences in the intensity of chronic refractory breathlessness. J Pain Symptom Manag. 2013;46:957\u201363. 10.1016\/j.jpainsymman.2013.01.011 .","journal-title":"J Pain Symptom Manag"},{"key":"535_CR27","doi-asserted-by":"publisher","unstructured":"Janowiak P, Damps-Konstanska I, Krajnik M, Podolec Z, Jassem E. Is nebulized morphine effective in treating persistent dyspnea in very severe COPD? A preliminary report. Eur Resp J. 2015;46(Suppl 59):PA3717. doi: 10.1183\/13993003.congress-2015.PA3717 .","DOI":"10.1183\/13993003.congress-2015.PA3717"},{"key":"535_CR28","first-page":"145","volume":"71","author":"MM Nieminen","year":"1987","unstructured":"Nieminen MM, Holli H, Lahdensuo A, Muittari A, Karvonen J. Aerosol deposition in automatic dosimeter nebulization. Eur J Respir Dis. 1987;71:145\u201352. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3678414","journal-title":"Eur J Respir Dis"},{"key":"535_CR29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/thx.50.6.629","volume":"50","author":"AR Masood","year":"1995","unstructured":"Masood AR, Reed JW, Thomas SH. Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease. Thorax. 1995;50:629\u201334. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7638804","journal-title":"Thorax"},{"key":"535_CR30","first-page":"64","volume":"10","author":"C Davis","year":"1996","unstructured":"Davis C, Penn K, A\u2019Hern R, Daniels J, Slevin M. Single dose randomised controlled trial of nebulised morphine in patients with cancer related breathlessness. Palliat Med. 1996;10:64\u20135.","journal-title":"Palliat Med"},{"key":"535_CR31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1378\/chest.104.1.175","volume":"104","author":"W Beauford","year":"1993","unstructured":"Beauford W, Saylor TT, Stansbury DW, Avalos K, Light RW. Effects of Nebulized morphine sulfate on the exercise tolerance of the Ventilatory limited COPD patient. Chest. 1993;104:175\u20138.","journal-title":"Chest"},{"key":"535_CR32","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.addr.2006.07.009","volume":"58","author":"G Scheuch","year":"2006","unstructured":"Scheuch G, Kohlhaeufl MJ, Brand P, Siekmeier R. Clinical perspectives on pulmonary systemic and macromolecular delivery. Adv Drug Deliv Rev. 2006;58:996\u20131008.","journal-title":"Adv Drug Deliv Rev"},{"key":"535_CR33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1023\/A:1012058323754","volume":"14","author":"J Schuster","year":"1997","unstructured":"Schuster J, Rubsamen R, Lloyd P, Lloyd J. The AERX aerosol delivery system. Pharm Res. 1997;14:354\u20137. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9098880","journal-title":"Pharm Res"},{"key":"535_CR34","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jpainsymman.2009.03.008","volume":"38","author":"M Krajnik","year":"2009","unstructured":"Krajnik M, Podolec Z, Siekierka M, Sykutera M, Pufal E, Sobanski P, et al. Morphine inhalation by cancer patients: a comparison of different Nebulization techniques using pharmacokinetic, Spirometric, and Gasometric parameters. J Pain Symptom Manag. 2009;38:747\u201357. 10.1016\/j.jpainsymman.2009.03.008 .","journal-title":"J Pain Symptom Manag"},{"key":"535_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0304-3959(03)00318-X","volume":"106","author":"D Fitzgibbon","year":"2003","unstructured":"Fitzgibbon D, Morgan D, Dockter D, Barry C, Kharasch ED. Initial pharmacokinetic, safety and efficacy evaluation of nasal morphine gluconate for breakthrough pain in cancer patients. Pain. 2003;106:309\u201315. 10.1016\/S0304-3959(03)00318-X .","journal-title":"Pain"},{"key":"535_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1067\/mcp.2001.118632","volume":"70","author":"MS Cepeda","year":"2001","unstructured":"Cepeda MS, Farrar JT, Roa JH, Boston R, Meng QC, Ruiz F, et al. Ethnicity influences morphine pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther. 2001;70:351\u201361. 10.1067\/mcp.2001.118632 .","journal-title":"Clin Pharmacol Ther"},{"key":"535_CR37","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/clpt.1993.149","volume":"54","author":"N Babul","year":"1993","unstructured":"Babul N, Darke AC. Disposition of morphine and its glucuronide metabolites after oral and rectal administration: evidence of route specificity. Clin Pharmacol Ther. 1993;54:286\u201392. 10.1038\/clpt.1993.149 .","journal-title":"Clin Pharmacol Ther"},{"key":"535_CR38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/clpt.1990.2","volume":"47","author":"R Osborne","year":"1990","unstructured":"Osborne R, Joel S, Trew D, Slevin M. Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther. 1990;47:12\u20139. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2295214","journal-title":"Clin Pharmacol Ther"},{"key":"535_CR39","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2165\/00003088-199324040-00007","volume":"24","author":"J Hasselstr\u00f6m","year":"1993","unstructured":"Hasselstr\u00f6m J, S\u00e4we J. Morphine pharmacokinetics and metabolism in humans: Enterohepatic cycling and relative contribution of metabolites to active Opioid concentrations. Clin Pharmacokinet. 1993;24:344\u201354. 10.2165\/00003088-199324040-00007 .","journal-title":"Clin Pharmacokinet"},{"key":"535_CR40","first-page":"A359","volume-title":"Proceedings of the annual meeting of the American Society of Clinical Oncology","author":"C Davis","year":"1992","unstructured":"Davis C, Lam W, Butcher M, Joel S, Slevin M. Low systemic bioavailability of nebulized morphine: potential therapeutic role for the relief of dyspnea. In: Proceedings of the annual meeting of the American Society of Clinical Oncology; 1992. p. A359."},{"key":"535_CR41","doi-asserted-by":"crossref","unstructured":"Masood AR, Thomas SH. Systemic absorption of nebulized morphine compared with oral morphine in healthy subjects. Br J Clin Pharmacol. 1996;41:\u2013250, 2. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8866928","DOI":"10.1111\/j.1365-2125.1996.tb00192.x"},{"key":"535_CR42","unstructured":"Viola R, Bak K, Cathy K, Martelli-Reid L, Poling M, Cameron A, et al. Cancer Care Ontario\u2019s symptom management guide-to-practice: Dyspnea. https:\/\/www.cancercare.on.ca\/cms\/one.aspx?portalId=1377&pageId=58189 . Accessed 30 Jan 2017."},{"key":"535_CR43","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0009-9236(97)90079-5","volume":"62","author":"ME Ward","year":"1997","unstructured":"Ward ME, Woodhouse A, Mather LE, Farr SJ, Okikawa JK, Lloyd P, et al. Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system. Clin Pharmacol Ther. 1997;62:596\u2013609. 10.1016\/S0009-9236(97)90079-5 .","journal-title":"Clin Pharmacol Ther"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-017-0535-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T20:49:29Z","timestamp":1570481369000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-017-0535-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["535"],"URL":"https:\/\/doi.org\/10.1186\/s12890-017-0535-y","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"186"}}